New study shows eating pulses every day improves blood vessel function and fights heart disease
Posted on: Monday, 20 April 2009, 12:07 CDT
A new clinical study by researchers at the Canadian Centre for Agri-Food Research in Health and Medicine (CCARM) shows that daily consumption of pulses - beans, peas, lentils and chickpeas - leads to major improvements in blood vessel function in individuals with peripheral arterial disease (PAD), a condition in which blood flow to the limbs is reduced. Study findings were presented today at the Experimental Biology conference in
Over 10 million people in
"Eating pulses brings back that arterial flexibility and may actually reverse the disease process," explains CCARM team leader Dr.
Regular pulse consumption also reduced the body mass index of study participants and significantly reduced circulating total and LDL cholesterol levels. Study findings also showed that regular pulse consumption increased the dietary intake of fibre, folate, Vitamin C, iron, zinc, potassium and protein.
"The study tells us that by making a few simple changes in your diet, you can improve your health significantly, potentially reducing the need for expensive pharmaceuticals," says Dr. Taylor. "Pulses are a true functional food - they may offer significant protection against cardiovascular disease, are readily available and the amount can be easily integrated into an everyday diet."
CCARM is a partnership between the
SOURCE Pulse Canada
Source: PR Newswire
Related Articles
- Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
- Hospitals, Healthcare Providers Will Save With Premier Agreements for Arterial Blood Gas Kits
- New Study Shows BENICAR(R) (Olmesartan Medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
- BioServe Selected By Specialized Clinical Center of Research for Study on Thoracic Aortic Disease
- Early Initiation Of INTEGRILIN(R) (Eptifibatide) for Heart-Attack Patients in Emergency Department Achieved Superior Coronary Artery Blood Flow
- Osta Biotechnologies Announces Promising Interim Results From Its Second Clinical Study on the Development of a Novel Blood Test for Osteoporosis
- Study Links Painkillers to Women's High Blood Pressure
- Nabi Biopharmaceuticals Initiates PhosLo(R) Epick Study in Chronic Kidney Disease Patients
- Combating Cardiovascular Disease With Compounded Medications: Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
- Study Suggests People Use at Home Blood Pressure Tests
User Comments (0)

RSS Feeds